Trafficking and proteolytic processing of APP.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cold Spring Harbor Perspectives in Medicine

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1101/cshperspect.a006270PMID 22553493PMCID PMC3331683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurotoxicity of amyloid β-protein: synaptic and network dysfunction.

  2012cited by this paper
• Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease.

  2012cited by this paper
• Treatment strategies targeting amyloid β-protein.

  2012cited by this paper
• Regulated intramembrane proteolysis – lessons from amyloid precursor protein processing

  2011cited by this paper
• Effects of Synaptic Modulation on β-Amyloid, Synaptophysin, and Memory Performance in Alzheimer's Disease Transgenic Mice

  2010cited by this paper
• Synaptic and Endosomal Localization of Active γ-Secretase in Rat Brain

  2010cited by this paper
• ADAM10 is the physiologically relevant, constitutive α‐secretase of the amyloid precursor protein in primary neurons

  2010influential reference
• Amyloid beta from axons and dendrites reduces local spine number and plasticity

  2010cited by this paper
• An APP inhibitory domain containing the Flemish mutation residue modulates γ-secretase activity for Aβ production

  2010cited by this paper
• Many Neuronal and Behavioral Impairments in Transgenic Mouse Models of Alzheimer's Disease Are Independent of Caspase Cleavage of the Amyloid Precursor Protein

  2010cited by this paper
• Glu-333 of Nicastrin Directly Participates in γ-Secretase Activity*

  2009cited by this paper
• Axonal Transport Defects in Neurodegenerative Diseases

  2009cited by this paper
• Alzheimer Disease Aβ Production in the Absence of S-Palmitoylation-dependent Targeting of BACE1 to Lipid Rafts*

  2009cited by this paper
• Intramembrane Proteolysis by Signal Peptide Peptidases: A Comparative Discussion of GXGD-type Aspartyl Proteases*

  2009cited by this paper
• APP Anterograde Transport Requires Rab3A GTPase Activity for Assembly of the Transport Vesicle

  2009influential reference
• γ-Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of β-Carboxyl Terminal Fragment

  2009cited by this paper
• Synaptic activity prompts γ-secretase–mediated cleavage of EphA4 and dendritic spine formation

  2009cited by this paper
• Function, regulation and therapeutic properties of beta-secretase (BACE1).

  2009cited by this paper
• Novel Role of RanBP9 in BACE1 Processing of Amyloid Precursor Protein and Amyloid β Peptide Generation*

  2009cited by this paper
• Substrate Requirements for SPPL2b-dependent Regulated Intramembrane Proteolysis*

  2009cited by this paper
• Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo.

  2008cited by this paper
• Intramembrane Proteolysis by γ-Secretase*

  2008cited by this paper
• Role of axonal transport in neurodegenerative diseases.

  2008cited by this paper
• Faculty Opinions recommendation of Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting.

  2008cited by this paper
• Efficient Inhibition of the Alzheimer's Disease β-Secretase by Membrane Targeting

  2008cited by this paper
• Neuregulin‐1, a key axonal signal that drives Schwann cell growth and differentiation

  2008cited by this paper
• Assembly, maturation, and trafficking of the gamma-secretase complex in Alzheimer's disease.

  2008cited by this paper
• Glu332 in the Nicastrin Ectodomain Is Essential for γ-Secretase Complex Maturation but Not for Its Activity*

  2008cited by this paper
• Intramembrane Proteolysis of GXGD-type Aspartyl Proteases Is Slowed by a Familial Alzheimer Disease-like Mutation*

  2008cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• β‐amyloid precursor protein can be transported independent of any sorting signal to the axonal and dendritic compartment

  2007influential reference
• SorLA/LR11 Regulates Processing of Amyloid Precursor Protein via Interaction with Adaptors GGA and PACS-1*

  2007cited by this paper
• The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

  2007cited by this paper
• BACE1 regulates voltage-gated sodium channels and neuronal activity

  2007cited by this paper
• Autophagy, amyloidogenesis and Alzheimer disease

  2007cited by this paper
• Physiological Mouse Brain Aβ Levels Are Not Related to the Phosphorylation State of Threonine-668 of Alzheimer's APP

  2006cited by this paper
• Bace1 modulates myelination in the central and peripheral nervous system

  2006cited by this paper
• A Basolateral Sorting Signal Directs ADAM10 to Adherens Junctions and Is Required for Its Function in Cell Migration*

  2006cited by this paper
• A gamma-secretase-like intramembrane cleavage of TNFalpha by the GxGD aspartyl protease SPPL2b.

  2006cited by this paper
• GGA1 Is Expressed in the Human Brain and Affects the Generation of Amyloid β-Peptide

  2006cited by this paper
• Control of Peripheral Nerve Myelination by the ß-Secretase BACE1

  2006cited by this paper
• A γ-secretase-like intramembrane cleavage of TNFα by the GxGD aspartyl protease SPPL2b

  2006cited by this paper
• The X11 proteins, Aβ production and Alzheimer's disease

  2006cited by this paper
• Subcellular Trafficking of the Amyloid Precursor Protein Gene Family and Its Pathogenic Role in Alzheimer’s Disease

  2006cited by this paper
• Assembly, trafficking and function of gamma-secretase.

  2006cited by this paper
• Inhibition of APP Trafficking by Tau Protein Does Not Increase the Generation of Amyloid‐β Peptides

  2006cited by this paper
• Presenilin-dependent gamma-secretase on plasma membrane and endosomes is functionally distinct.

  2006cited by this paper
• The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments

  2006influential reference
• Amyloid Precursor Protein and Notch Intracellular Domains are Generated after Transport of their Precursors to the Cell Surface

  2006cited by this paper
• The X11 proteins, Abeta production and Alzheimer's disease.

  2006cited by this paper
• Nicastrin functions as a gamma-secretase-substrate receptor.

  2005cited by this paper
• Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory

  2005cited by this paper
• Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase.

  2005cited by this paper
• Rapid Endocytosis of the Low Density Lipoprotein Receptor-related Protein Modulates Cell Surface Distribution and Processing of the β-Amyloid Precursor Protein*

  2005cited by this paper
• NMDA Receptor Activation Inhibits α-Secretase and Promotes Neuronal Amyloid-β Production

  2005cited by this paper
• γ-Secretase Exists on the Plasma Membrane as an Intact Complex That Accepts Substrates and Effects Intramembrane Cleavage*

  2005cited by this paper
• GGA Proteins Mediate the Recycling Pathway of Memapsin 2 (BACE)*

  2005cited by this paper
• Nicastrin Functions as a γ-Secretase-Substrate Receptor

  2005cited by this paper
• Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid β protein

  2005cited by this paper
• Phenotypic and Biochemical Analyses of BACE1- and BACE2-deficient Mice*

  2005cited by this paper
• NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production.

  2005cited by this paper
• GGA proteins regulate retrograde transport of BACE1 from endosomes to the trans-Golgi network.

  2005cited by this paper
• Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

  2005influential reference
• Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.

  2005influential reference
• Longer Forms of Amyloid β Protein: Implications for the Mechanism of Intramembrane Cleavage by γ-Secretase

  2005cited by this paper
• Regulation of NMDA receptor trafficking by amyloid-beta.

  2005cited by this paper
• Axonal Transport, Amyloid Precursor Protein, Kinesin-1, and the Processing Apparatus: Revisited

  2005cited by this paper
• Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.

  2005cited by this paper
• The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor

  2004cited by this paper
• Neuronal membrane cholesterol loss enhances amyloid peptide generation

  2004cited by this paper
• A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.

  2004influential reference
• Processing of Notch and amyloid precursor protein by γ-secretase is spatially distinct

  2004cited by this paper
• FE65 Constitutes the Functional Link between the Low-Density Lipoprotein Receptor-Related Protein and the Amyloid Precursor Protein

  2004cited by this paper
• Processing of Notch and amyloid precursor protein by gamma-secretase is spatially distinct.

  2004cited by this paper
• Requirement of PEN-2 for Stabilization of the Presenilin N-/C-terminal Fragment Heterodimer within the γ-Secretase Complex*

  2004cited by this paper
• Both the Sequence and Length of the C Terminus of PEN-2 Are Critical for Intermolecular Interactions and Function of Presenilin Complexes*

  2004cited by this paper
• Take five—BACE and the γ‐secretase quartet conduct Alzheimer's amyloid β‐peptide generation

  2004influential reference
• Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation.

  2004influential reference
• BACE1: the beta-secretase enzyme in Alzheimer's disease.

  2004influential reference
• Beta-secretase inhibition for the treatment of Alzheimer's disease--promise and challenge.

  2004cited by this paper
• APP processing is regulated by cytoplasmic phosphorylation

  2003cited by this paper
• Inhibition of Receptor-mediated Endocytosis Demonstrates Generation of Amyloid β-Protein at the Cell Surface*

  2003cited by this paper
• Exclusively targeting β-secretase to lipid rafts by GPI-anchor addition up-regulates β-site processing of the amyloid precursor protein

  2003cited by this paper
• Antagonistic Effects of β-Site Amyloid Precursor Protein-cleaving Enzymes 1 and 2 on β-Amyloid Peptide Production in Cells*

  2003cited by this paper
• Antagonistic effects of beta-site amyloid precursor protein-cleaving enzymes 1 and 2 on beta-amyloid peptide production in cells.

  2003cited by this paper
• Presenilin‐1 Exists in Both Pre‐ and Post‐Golgi Compartments and Recycles Via COPI‐Coated Membranes

  2003cited by this paper
• ADAMs family members as amyloid precursor protein alpha-secretases.

  2003cited by this paper
• The role of the endosomal/ lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: Reexamining the spatial paradox from a lysosomal perspective

  2003cited by this paper
• Munc18 Interacting Proteins

  2003cited by this paper
• Treatment with the selective muscarinic ml agonist talsaclidine decreases cerebrospinal fluid levels of Aβ42 in patients with Alzheimer's disease

  2003cited by this paper
• APP processing and synaptic function.

  2003cited by this paper
• BACE1 (beta-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes.

  2003cited by this paper
• Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)*

  2003cited by this paper
• Reconstitution of γ-secretase activity

  2003cited by this paper
• Caspase cleavage of the amyloid precursor protein modulates amyloid β‐protein toxicity

  2003cited by this paper
• Alzheimer's disease proteins in cerebellar and hippocampal synapses during postnatal development and aging of the rat.

  2003cited by this paper
• BACE1 (β-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time

  2003cited by this paper
• Reconstitution of gamma-secretase activity.

  2003cited by this paper
• Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration.

  2003cited by this paper
• Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts

  2003cited by this paper

• APP‐mediated intracellular signaling rescues sleep impairment and blood–brain barrier leakage in Alzheimer's disease mouse model

  2026cites this paper
• A Novel APP p.V742L variant in a patient with ischemic small vessel disease enhances FE65 signalling.

  2026cites this paper
• Recent Advances in Erinacine A: Preparation, Biological Activities, and Biosynthetic Pathway

  2026cites this paper
• Linking dietary patterns to Alzheimer's disease biomarkers with network mathematical modeling could enable new approach methodologies in preventative AD research: a narrative interdisciplinary review

  2026cites this paper
• Impact of Golgi dynamics and Golgi morphology on the regulation of glycosylation.

  2026cites this paper
• Mechanisms of electroacupuncture for the treatment of Alzheimer's disease by activating Wnt/β-catenin pathway to improve blood-brain barrier function

  2026cites this paper
• Synaptic Vesicle Glycoprotein 2A Suppresses Amyloidogenesis Beyond Its Synaptic Role: A Novel Mechanism Disrupting BACE1 Binding and Altering APP Localization

  2026cites this paper
• Modeling Late-Onset Sporadic Alzheimer’s Disease Using Patient-Derived Cells: A Review

  2026cites this paper
• Click Chemistry‐Aided Synthesis of Triazole‐Tethered Benzothiazoles as Novel Multifunctional Agents Against Alzheimer's Disease

  2025cites this paper
• Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review

  2025cites this paper
• The pathophysiology of mixed Alzheimer's disease and vascular dementia

  2025cites this paper
• Deciphering Alzheimer’s disease transcriptomics: exploration and validation of core genes in tau and Aβ pathological models toward novel therapeutic targets

  2025cites this paper
• Ms4a4a deficiency ameliorates plaque pathology in a mouse model of amyloid accumulation

  2025cites this paper
• The Key Flavor Substance in Zanthoxylum Preventing Alzheimer's Disease through Insulin Signaling.

  2025cites this paper
• Adipose tissue-derived mesenchymal stem cell extracellular vesicles enhance amyloid-beta degradation in an in vitro Alzheimer's model.

  2025cites this paper
• Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment

  2025cites this paper
• Loss of the APP regulator RHBDL4 preserves memory in an Alzheimer’s disease mouse model

  2025cites this paper
• Cathepsin B inhibition blocks amyloidogenesis in the mouse models of neurological lysosomal diseases MPS IIIC and sialidosis

  2025cites this paper
• Aerobic exercise improves clearance of amyloid-β via the glymphatic system in a mouse model of Alzheimer's Disease.

  2025cites this paper
• Untangling the Genetic Threads of Alzheimer's: Insights into Risk Factors and Biomarkers.

  2025cites this paper
• An unraveled mystery: What's the role of brain sphingolipids in neurodegenerative and psychiatric disorders.

  2025cites this paper
• Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)

  2025cites this paper
• CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk

  2025cites this paper
• Intracellular and Extracellular Localization of Transthyretin and Its Association With Amyloid‐β in Alzheimer's Disease Brains

  2025cites this paper
• Distinct composition of different types of Abeta plaques in the pathogenesis of Alzheimer’s disease and the role of neutrophil-derived myeloperoxidase

  2025cites this paper
• Decoding Glycosylation in Neurodegenerative Diseases: Mechanistic Insights and Therapeutic Opportunities

  2025cites this paper
• Munc 18-1 is a multifaceted therapeutic target for Dementia.

  2025cites this paper
• Circulating Micro RNAs as Diagnostic Signatures for Amyloid Beta Toxicity in Alzheimer's Disease

  2025cites this paper
• Fluid biomarkers for neurodegenerative diseases: a comprehensive update

  2025cites this paper
• Engineered Stem Cell Membrane-Coated Nanodrugs for Targeted Therapy of Alzheimer's Disease.

  2025cites this paper
• Novel Approaches to Track Neurodegeneration in Murine Models of Alzheimer’s Disease Reveal Previously Unknown Aspects of Extracellular Aggregate Deposition

  2025cites this paper
• Accurate determination of the preferred aggregation number of a micelle-encapsulated membrane protein dimer

  2025cites this paper
• Enrichment of phosphorylated Tau 181 levels in tear fluid-derived extracellular vesicles.

  2025cites this paper
• APOE4-APP interactions exert early influences on cerebrovascular structure and function: implications for Alzheimer’s disease

  2025cites this paper
• Aluminum Exposure Leads to Aβ Deposition via the ciRs-7 Pathway.

  2025cites this paper
• Recent advances in symptomatic management and immunotherapies for Alzheimer's disease treatment: a narrative review

  2025cites this paper
• RABGAP1 is a sensor that facilitates the sorting and processing of amyloid precursor protein

  2025influential citation
• Dynamic changes of hippocampal dendritic spines in Alzheimer's disease mice among the different stages.

  2025cites this paper
• Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer’s dementia continuum: an [18 F] AV-45 study

  2025cites this paper
• Beneficial Effects of the Herbal Medicine Zuo Gui Wan in a Mice Model of Alzheimer's Disease via Drp1-Mediated Inhibition of Mitochondrial Fission and Activation of AMPK/PGC-1α-regulated Mitochondrial Bioenergetics.

  2025cites this paper
• A Novel Missense Variant in SORBS2 Is Causative With Familial Alzheimer's Disease

  2025cites this paper
• Blood biomarkers to identify patients with different intracranial lesion combinations after traumatic brain injury

  2025cites this paper
• THICAPA modulates amyloid precursor protein processing and alleviates oxidative stress in fibroblasts derived from patients with Familial Alzheimer’s disease

  2025cites this paper
• Adolescent Alcohol and the Spectrum of Cognitive Dysfunction in Aging.

  2025cites this paper
• Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms

  2025cites this paper
• Selectivity, stability, and pharmacokinetic profiling of Spongia-derived steroids targeting AChE and BuChE for Alzheimer’s therapy

  2025cites this paper
• Pathophysiology of Alzheimer’s Disease: Herbal Neurogenesis and Synthetic Molecular Interventions

  2025cites this paper
• In silico profiling of neem limonoids and gut microbiome metabolites for Alzheimer’s therapeutics: targeted inhibition of BACE1 and elucidation of intricate molecular crosstalk with tau oligomers, and bacterial gingipains

  2025cites this paper
• Genetic and environmental risk factors for dementia in African adults: A systematic review

  2025cites this paper
• Active Immunization Targeting Amyloid β for the Treatment of Alzheimer’s Disease

  2025cites this paper
• Amyloid precursor protein carboxy-terminal fragments as catalyzers of endolysosomal dysfunction in Alzheimer's disease.

  2025cites this paper
• Peptide-loaded chitosan nanoparticles improve mitochondrial and cognitive functions via inhibition of Aβ-ABAD interaction in Alzheimer's disease.

  2025cites this paper
• Vesicular trafficking and cell-cell communication in neurodevelopment and neurodegeneration

  2025cites this paper
• Impairment of Tricarboxylic Acid Cycle (TCA) Cycle in Alzheimer's Disease: Mechanisms, Implications, and Potential Therapies

  2025cites this paper
• NCAM2 promotes targeting of APP from the cell surface to BACE1-containing recycling endosomes.

  2025cites this paper
• Amyloid-β protein precursor modulates mitophagy and mitochondrial function through its cellular localization

  2025cites this paper
• Golgi defect as a major contributor to lysosomal dysfunction

  2024influential citation
• The growth rate of senile plaques is determined by the competition between the rate of deposition of free Aβ aggregates into plaques and the autocatalytic production of free Aβ aggregates

  2024cites this paper
• Inhibition of Autophagy Alters Intracellular Transport of APP Resulting in Increased APP Processing

  2024cites this paper
• STAU1 exhibits a dual function by promoting amyloidogenesis and tau phosphorylation in cultured cells.

  2024cites this paper
• In vitro cleavage of tumor necrosis factor α (TNFα) by Signal-Peptide-Peptidase-like 2b (SPPL2b) resembles mechanistic principles observed in the cellular context.

  2024cites this paper
• Nanodisc reconstitution and characterization of amyloid-β precursor protein C99

  2024cites this paper
• Multi-strain probiotics ameliorates Alzheimer's-like cognitive impairment and pathological changes through the AKT/GSK-3β pathway in senescence-accelerated mouse prone 8 mice.

  2024cites this paper
• The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes

  2024cites this paper
• Trimetazidine attenuates neuroinflammation via TLR4/NF-KB pathway inhibition in lipopolysaccharides-induced dementia in rats

  2024cites this paper
• Strategies for measuring concentrations and forms of amyloid-β peptides.

  2024cites this paper
• Extracellular Vesicles Slow Down Aβ(1–42) Aggregation by Interfering with the Amyloid Fibril Elongation Step

  2024cites this paper
• Loss of the APP regulator RHBDL4 preserves memory in an Alzheimer’s disease mouse model

  2024cites this paper
• Hyperfunction of post-synaptic density protein 95 promotes seizure response in early-stage aβ pathology

  2024cites this paper
• Which neuroimaging and fluid biomarkers method is better in theranostic of Alzheimer’s disease? An umbrella review

  2024cites this paper
• Tauroursodeoxycholic acid: a bile acid that may be used for the prevention and treatment of Alzheimer’s disease

  2024cites this paper
• Emerging structures and dynamic mechanisms of γ-secretase for Alzheimer’s disease

  2024cites this paper
• CoVAMPnet: Comparative Markov State Analysis for Studying Effects of Drug Candidates on Disordered Biomolecules

  2024cites this paper
• RACK1 and IRE1 participate in the translational quality control of amyloid precursor protein in Drosophila models of Alzheimer’s disease

  2024cites this paper
• Bridging Ayurveda and modern neurology: A Co.M.S. (collaborative medicine and science) approach to Alzheimer’s disease

  2024cites this paper
• Endothelial leakiness elicited by amyloid protein aggregation

  2024cites this paper
• Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer’s disease mouse model by regulating the expression of APP secretases

  2024cites this paper
• Profiling amyloid‐β peptides as biomarkers for cerebral amyloid angiopathy

  2024cites this paper
• Fluid-based biomarkers in neurodegeneration: Current findings and future directions

  2024cites this paper
• Endosomal traffic disorders: a driving force behind neurodegenerative diseases

  2024cites this paper
• Liquid–liquid phase separation in Alzheimer’s disease

  2024cites this paper
• The deacetylase SIRT6 reduces amyloid pathology and supports cognition in mice by reducing the stability of APP in neurons.

  2024cites this paper
• Recent advancements in the therapeutic approaches for Alzheimer's disease treatment: current and future perspective

  2024cites this paper
• Role of dietary and nutritional interventions in ceramide-associated diseases

  2024cites this paper
• Silencing Apoe with divalent‐siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease

  2024cites this paper
• Nanotechnology in the diagnostic and therapy for Alzheimer's disease.

  2024cites this paper
• Investigating Cu(I) binding to model peptides of N-terminal Aβ isoforms.

  2024cites this paper
• Generation of Stable Cell Lines of APP695 (K595N, M596L) Gene Over-Expression via Lentiviral Over-Expression System

  2024cites this paper
• Amyloid Modifier SERF1a Accelerates Alzheimer's Amyloid-β Fibrillization and Exacerbates the Cytotoxicity.

  2024cites this paper
• Numerical modeling of senile plaque development under conditions of limited diffusivity of amyloid-β monomers

  2024cites this paper
• Steroidogenic Acute Regulatory Protein Mediated Variations of Gender-Specific Sex Neurosteroids in Alzheimer's Disease: Relevance to Hormonal Imbalance.

  2024cites this paper
• New horizons in the diagnosis and management of Alzheimer’s Disease in older adults

  2024cites this paper
• Integrating rare pathogenic variant prioritization with gene‐based association analysis to identify novel genes and relevant multimodal traits for Alzheimer's disease

  2024cites this paper
• Serum Tau-A and Tau-C Levels and Their Association with Cognitive Impairment and Dementia Progression in a Memory Clinic Derived Cohort

  2024cites this paper
• Effect of the aggregation state of amyloid-beta (25-35) on the brain oxidative stress in vivo

  2024cites this paper
• Vesicular Transport and Amyloids: The Growing Relationship

  2024cites this paper
• Multitarget Neuroprotective Effects of Quercetin on the Pathogenesis of Amyloid-β1-42 in Alzheimer’s Disease: In-vitro and In-silico study

  2024cites this paper
• The role and mechanism of dapagliflozin in Alzheimer disease: A review

  2024cites this paper
• Numerical and analytical simulation of the growth of amyloid-β plaques

  2024cites this paper
• Novel Piperazine Based Compounds Target Alzheimer's Disease Relevant Amyloid β42 and Tau Derived Peptide AcPHF6, and the Lead Molecule Increases Viability in the Flies Expressing Human Tau Protein.

  2024cites this paper